Keyphrases
Access to Treatment
30%
Accountable Care Organizations
30%
Black Americans
30%
Buprenorphine
73%
Buprenorphine Treatment
75%
Counseling
30%
COVID-19 Infection
30%
COVID-19 Mortality
30%
Customer Acquisition
30%
Death by Suicide
30%
Emergency Department
30%
Harm Reduction
30%
Harm Reduction Services
37%
Hazard Ratio
62%
Healthcare Expenditure
30%
High Risk
34%
High Threshold
30%
Hospital Quality Improvement
30%
Insomnia
30%
Insomnia Medications
30%
Medicare
60%
Medicare Beneficiaries
41%
Medications for Opioid Use Disorder
63%
Opioid Overdose
48%
Opioid Use Disorder
100%
Opioids
57%
Overdose Deaths
43%
Paragraph IV
30%
Patent Characteristics
30%
Patent Litigation
30%
Pharmaceutical Industry
30%
Prescribers
32%
Quality Improvement Program
30%
Racial Disparities
30%
Risk of Death
30%
Self-harm
30%
Small Practices
30%
Social Determinants of Health (SDoH)
26%
Stimulants
30%
Suicide Attempt
30%
Suicide Risk
29%
Treatment Gap
30%
Treatment Outcome
30%
Treatment Pathways
30%
Treatment Termination
30%
US Medicare
33%
Vitamin D
42%
Vitamin D Status
30%
Vitamin D Supplementation
42%
Vitamin D3
30%
Medicine and Dentistry
Accountable Care Organization
30%
Adolescence
20%
Adolescent Health
10%
All Cause Mortality
15%
Analeptic
21%
Asian Pacific Islanders
8%
Asthma
7%
Buprenorphine
84%
Combination Therapy
24%
Counseling
25%
COVID-19 Vaccination
7%
Disease
7%
Drug Screening
20%
Drug Therapy
8%
Eating Disorder
10%
Emergency Department
67%
Ethnic Disparity
30%
Fentanyl
12%
Harm Reduction
30%
Hazard Ratio
20%
Health Care
30%
Health Care Provider
10%
Health Outcomes
15%
Health Service
10%
Intoxication
7%
Medicare
60%
Mental Health
30%
Mental Health Recovery
30%
Methadone
30%
Naloxone
12%
Naltrexone
17%
Opiate
55%
Opioid Abuse
72%
Opioid Crisis
30%
Outpatient
12%
Patient Dropout
30%
Patient Health Questionnaire
10%
Patient Health Questionnaire 9
20%
Patient Referral
7%
Prematurity
10%
Proportional Hazards Model
10%
Public Health
30%
Quality Improvement
23%
Racial Disparity
30%
Social Determinants of Health
44%
Subgroup Analysis
10%
Substance Use Disorder
44%
Nursing and Health Professions
Accountable Care Organization
90%
All Cause Mortality
15%
Alzheimer's Disease
9%
Amitriptyline
5%
Antihistaminic Agent
5%
Asthma
7%
Benadryl
5%
Central Stimulant Agent
32%
Combination Therapy
10%
Convergent Validity
7%
Cross-Sectional Study
6%
Disease
27%
Disease Control
7%
Diseases
30%
Doxepin
5%
Drug Dependence
30%
Drug Therapy
30%
Duragesic
12%
Electronic Medical Record
5%
Emergency Ward
7%
Generalized Anxiety Disorder
5%
Harm Reduction
30%
Health Outcomes
18%
Hospital Readmission
41%
Household
16%
Hydroxyzine
5%
Hypnotic Sedative Agent
5%
Length of Stay
13%
Major Depression
5%
Medicare
35%
Mental Health
30%
Mirtazapine
5%
Naloxone
12%
Nurse Practitioner
30%
Nursing
30%
Nursing Home
53%
Nutrition Policy
30%
Odds Ratio
30%
Predictive Validity
7%
Prevalence
30%
Prophylaxis
7%
Proportional Hazards Model
5%
Public Health Service
15%
Social Determinants of Health
22%
Test Strip
12%
Tetracyclic Antidepressant Agent
5%
Tricyclic Antidepressant
5%
Zolpidem
15%
